~~<i id='AC910499F8'><strike id='AC910499F8'><tt id='AC910499F8'><pre id='AC910499F8'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：knowledge 2025-09-27 17:07:54 Page View：3686

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Gain of function research would be limited under House proposal
Next article： New air purifier tech could be key to improving indoor air quality

comprehensive

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

AdobePHILADELPHIA—NovoNordisk,whichhasdominatedthediabetesandobesitymarketswithitsblockbusterdrugsOz

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

Astellas still sees hope in its gene therapy after four deaths

AdobeAgenetherapystudy,haltedwhenfourchildrenwitharareneuromusculardisorderdiedaftertreatment,showed